Suppr超能文献

社区老年队列中前驱糖尿病、糖尿病与无残疾生存时间损失:老年人用阿司匹林减少事件(ASPirin in Reducing Events in the Elderly,简称 ASPREE)试验的事后分析。

Prediabetes, diabetes and loss of disability-free survival in a community-based older cohort: a post-hoc analysis of the ASPirin in Reducing Events in the Elderly trial.

机构信息

School of Public Health and Preventive Medicine, Monash University, Melbourne, VIC, Australia.

Menzies Institute for Medical Research, University of Tasmania, Hobart, TAS, Australia.

出版信息

Age Ageing. 2023 Apr 1;52(4). doi: 10.1093/ageing/afad060.

Abstract

BACKGROUND

Evidence for the prognostic implications of hyperglycaemia in older adults is inconsistent.

OBJECTIVE

To evaluate disability-free survival (DFS) in older individuals by glycaemic status.

METHODS

This analysis used data from a randomised trial recruiting 19,114 community-based participants aged ≥70 years, who had no prior cardiovascular events, dementia and physical disability. Participants with sufficient information to ascertain their baseline diabetes status were categorised as having normoglycaemia (fasting plasma glucose [FPG] < 5.6 mmol/l, 64%), prediabetes (FPG 5.6 to <7.0 mmol/l, 26%) and diabetes (self-report or FPG ≥ 7.0 mmol/l or use of glucose-lowering agents, 11%). The primary outcome was loss of disability-free survival (DFS), a composite of all-cause mortality, persistent physical disability or dementia. Other outcomes included the three individual components of the DFS loss, as well as cognitive impairment-no dementia (CIND), major adverse cardiovascular events (MACE) and any cardiovascular event. Cox models were used for outcome analyses, with covariate adjustment using inverse-probability weighting.

RESULTS

We included 18,816 participants (median follow-up: 6.9 years). Compared to normoglycaemia, participants with diabetes had greater risks of DFS loss (weighted HR: 1.39, 95% CI 1.21-1.60), all-cause mortality (1.45, 1.23-1.72), persistent physical disability (1.73, 1.35-2.22), CIND (1.22, 1.08-1.38), MACE (1.30, 1.04-1.63) and cardiovascular events (1.25, 1.02-1.54) but not dementia (1.13, 0.87-1.47). The prediabetes group did not have an excess risk for DFS loss (1.02, 0.93-1.12) or other outcomes.

CONCLUSIONS

Among older people, diabetes was associated with reduced DFS, and higher risk of CIND and cardiovascular outcomes, whereas prediabetes was not. The impact of preventing or treating diabetes in this age group deserves closer attention.

摘要

背景

高血糖对老年人预后的影响证据并不一致。

目的

评估血糖状态与老年人无残疾生存(DFS)的关系。

方法

本分析使用了一项随机试验的数据,该试验招募了 19114 名年龄在 70 岁及以上、无心血管事件、痴呆和身体残疾的社区居民。有足够信息确定其基线糖尿病状态的参与者分为血糖正常(空腹血糖[FPG]<5.6mmol/L,占 64%)、糖尿病前期(FPG 5.6 至<7.0mmol/L,占 26%)和糖尿病(自我报告或 FPG≥7.0mmol/L 或使用降糖药物,占 11%)。主要结局是无残疾生存(DFS)丧失,包括全因死亡率、持续性身体残疾或痴呆。其他结局包括 DFS 丧失的三个单独组成部分,以及认知障碍但无痴呆(CIND)、主要不良心血管事件(MACE)和任何心血管事件。采用 Cox 模型进行结局分析,并使用逆概率加权进行协变量调整。

结果

共纳入 18816 名参与者(中位随访时间:6.9 年)。与血糖正常相比,糖尿病患者的 DFS 丧失风险更高(加权 HR:1.39,95%CI 1.21-1.60)、全因死亡率(1.45,1.23-1.72)、持续性身体残疾(1.73,1.35-2.22)、CIND(1.22,1.08-1.38)、MACE(1.30,1.04-1.63)和心血管事件(1.25,1.02-1.54),但痴呆风险无显著差异(1.13,0.87-1.47)。糖尿病前期组DFS 丧失风险(1.02,0.93-1.12)或其他结局均无显著升高。

结论

在老年人中,糖尿病与 DFS 降低以及更高的 CIND 和心血管结局风险相关,而糖尿病前期则无显著关联。在该年龄组预防或治疗糖尿病的影响值得进一步关注。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c65/10128162/bbd7ddb12f61/afad060f1.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验